Skip to content

The impact of anti-infective therapy on the clinical outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease

The impact of anti-infective therapy on the clinical outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500098483
Enrollment
Unknown
Registered
2025-03-10
Start date
2023-12-01
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Interventions

Non-antibiotic group:NA
Use antibiotic group:NA

Sponsors

The University of Hongkong - Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.The diagnosis was acute exacerbation of chronic obstructive pulmonary disease; 2.Inpatient; 3.There were results of pulmonary ventilation function test before hospitalization; 4.Results of serum PCT and CRP levels were obtained within 48 hours of hospitalization and before discharge; 5.Records of at least 2 visits within 2 years (more than 90 days apart), or including readmissions within 90 days of discharge, or death records;

Exclusion criteria

Exclusion criteria: 1.No complete medical records; 2.Discharge within 48 hours of admission; 3.Transferred patient; 4.Diagnosis of other infections requiring the use of antibiotics; 5.Complicated with serious heart, liver, kidney, brain and other system diseases; 6.Patients with malignant tumors or autoimmune diseases; 7.Patients with a recent history of surgery or trauma;

Design outcomes

Primary

MeasureTime frame
Rate of unplanned readmissions within 30 days;

Secondary

MeasureTime frame
Days of antibiotic use;Length of hospitalization;Invasive ventilation rate in hospital;In-hospital mortality rate;Serum CRP level;Serum PCT level;The number of acute exacerbations that occurred within 2 years;Time between discharge and next acute exacerbation;90-day unplanned readmission rate;Results of bacterial cultures readmitted within 90 days;

Countries

China

Contacts

Public ContactYang Zhicheng

The University of Hongkong - Shenzhen Hospital

yangzc@hku-szh.org+86 755 8691 3333

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026